Table of Contents
Literature Highlights
| Pembrolizumab as First-line Therapy for PD-L1-expressing Lung Cancer |
Abstract PDF |
| M. Saeed Sheikh |
13 |
FDA Corner
| FDA approves first drug for spinal muscular atrophy |
Abstract PDF |
| |
15 |
| FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes |
Abstract PDF |
| |
16 |
| FDA grants accelerated approval to first drug for Duchenne muscular dystrophy |
Abstract PDF |
| |
16-17 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
